Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

Inclusion Criteria: * Subjects must have a clinically documented diagnosis of age-related cataract that is considered amenable to treatment with standard phacoemulsification/extracapsular cataract extraction. * Subjects must be undergoing primary intraocular lens implantation for the correction of aphakia following continuous curvilinear anterior capsulotomy and phacoemulsification cataract extraction. * Subjects must require a lens power from 15 to 30 diopters. * Subjects must have a visual potential of 20/40 or better in the study eye. Exclusion Criteria: * Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated. * Subjects with any inflammation or edema (swelling) of the cornea. * Subjects with uncontrolled glaucoma or glaucoma under current treatment in the study eye or with ocular hypertension. * Subjects with previous retinal detachment. * Subjects with diabetic retinopathy (proliferative or non-proliferative). * Subjects with rubella, bilateral congenital, traumatic, or complicated cataract. * Subjects who have had previous ocular surgery in the planned operative eye, excluding ocular adnexa surgery. * Subjects who have already received an Akreos TL IOL in the fellow eye.